Cargando…
Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils
The amyloid aggregation of alpha-synuclein within the brain is associated with the pathogenesis of Parkinson’s disease (PD) and other related synucleinopathies, including multiple system atrophy (MSA). Alpha-synuclein aggregates are a major therapeutic target for treatment of these diseases. We iden...
Autores principales: | Murray, Kevin A., Hu, Carolyn J., Pan, Hope, Lu, Jiahui, Abskharon, Romany, Bowler, Jeannette T., Rosenberg, Gregory M., Williams, Christopher K., Elezi, Gazmend, Balbirnie, Melinda, Faull, Kym F., Vinters, Harry V., Seidler, Paul M., Eisenberg, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963379/ https://www.ncbi.nlm.nih.gov/pubmed/36757890 http://dx.doi.org/10.1073/pnas.2217835120 |
Ejemplares similares
-
De novo designed protein inhibitors of amyloid aggregation and seeding
por: Murray, Kevin A., et al.
Publicado: (2022) -
Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro
por: Seidler, Paul M., et al.
Publicado: (2022) -
Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies
por: Wu, Shenjie, et al.
Publicado: (2023) -
Bioinformatic identification of previously unrecognized amyloidogenic proteins
por: Rosenberg, Gregory M., et al.
Publicado: (2022) -
Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human α-Synuclein
por: Sarafian, Theodore A., et al.
Publicado: (2013)